Mivacurium en es it fr

Mivacurium Brand names, Mivacurium Analogs

Mivacurium Brand Names Mixture

  • No information avaliable

Mivacurium Chemical_Formula


Mivacurium RX_link


Mivacurium fda sheet

Mivacurium FDA

Mivacurium msds (material safety sheet)

Mivacurium MSDS

Mivacurium Synthesis Reference

No information avaliable

Mivacurium Molecular Weight

1029.26 g/mol

Mivacurium Melting Point

No information avaliable

Mivacurium H2O Solubility

No information avaliable

Mivacurium State


Mivacurium LogP

No information avaliable

Mivacurium Dosage Forms

Solution (sterile, non-pyrogenic, with pH 3.5 to 5.0 containing mivacurium chloride equivalent to 2 mg/mL mivacurium in water for injection)

Mivacurium Indication

For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Mivacurium Pharmacology

Mivacurium is a short-acting, nondepolarizing skeletal neuromuscular blocking agent which is hydrolyzed by plasma cholinesterase. Mivacurium results in a blockade of neuromuscular transmission by binding competitively with cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine. The neuromuscular block produced by mivacurium is readily antagonized by anticholinesterase agents. The deeper the level of neuromuscular block at reversal, the longer the time required for recovery of neuromuscular function and the greater the dose of anticholinesterase agent required. Because spontaneous recovery after mivacurium is rapid, routine reversal may not always result in a clinical benefit.

Mivacurium Absorption

No information avaliable

Mivacurium side effects and Toxicity

Overdosage with neuromuscular blocking agents may result in neuromuscular block beyond the time needed for surgery and anesthesia.

Mivacurium Patient Information

Mivacurium Organisms Affected

Humans and other mammals